Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2

Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases, and for the most cancer-related deaths. The survival pathway of Akt, its downstream effectors, the mammalian target of rapamycin (mTOR) and ribosomal protein S6 kinase (p70 S6K), and the Ras-extracellular signal-regulated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurgan, Nigel, Tsakiridis, Evelyn, Kouvelioti, Rozalia, Moore, Jessy, Klentrou, Panagiota, Tsiani, Evangelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447956/
https://www.ncbi.nlm.nih.gov/pubmed/28481292
http://dx.doi.org/10.3390/cancers9050046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447956/
https://www.ncbi.nlm.nih.gov/pubmed/28481292
http://dx.doi.org/10.3390/cancers9050046

Ejemplares similares